CHIA-YU CHUChen Y.-L.Lin L.-J.Sun C.-C.2019-12-042019-12-0420031018-8665https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037640951&doi=10.1159%2f000069949&partnerID=40&md5=0556c59061d41f86c0d1d9f1a099dc75https://scholars.lib.ntu.edu.tw/handle/123456789/435005[SDGs]SDG3anthranilic acid derivative; antiinflammatory agent; arylpropionic acid derivative; benoxaprofen; bufexamac; carbamazepine; carbomer; carprofen; diclofenac; etofenamate; fenamic acid derivative; flufenamic acid; flurbiprofen; indometacin; ketoprofen; meclofenamate sodium; mefenamic acid; nickel sulfate; niflumic acid; nonsteroid antiinflammatory agent; piroxicam; propylene glycol; pyrazolone; pyrazolone derivative; tiaprofenic acid; adult; arthritis; case report; contact dermatitis; cross allergy; cross reaction; drug screening; drug withdrawal; erythema; human; informed consent; letter; male; myalgia; patch test; photoallergy; photosensitivity; priority journal; pruritus; rheumatic disease; skin allergy; skin bruising; skin defect; skin irritation; skin manifestation; sprain; sun exposure; tenosynovitis; thigh; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cross Reactions; Dermatitis, Allergic Contact; Diclofenac; Flufenamic Acid; Humans; Ketoprofen; Male; Patch Tests; Thighletter10.1159/000069949127714782-s2.0-0037640951